The New Product of Mass Spectrometer Launched by ThermoFisher & Runda

Thermo Fisher

On November 30, Thermo Fisher Scientific held the unveiling ceremony of the first domestic gas chromatography-mass spectrometry in Suzhou factory. Mr. Zhou Xiaobin, vice president of business operation of analytical instrument business in China, said: congratulations on the first gas chromatography-mass spectrometry instrument produced in Suzhou, China. Thermo Fisher practices the promise of “in China, for China”, so that we can supply better and high-qualified products to Chinese users.

The localization of gas chromatography-mass spectrometry has important milestone significance, which means that Thermo Fisher has established a closer relationship with customers in China to making the world healthier, cleaner and safer.

The company actively embraces the wave of localization. The domestic instrument family of Thermo Fisher GC-MS business has expanded to 8 products: China-made liquid chromatograph, gas chromatograph, single quadrupole GC-MS, triple quadrupole GC-MS ion chromatographs, atomic absorption spectrometers, inductively coupled plasma spectrometers and inductively coupled plasma mass spectrometers have fully blossomed in vertical markets such as food, environment, industry, pharmaceutical and biopharmaceutical. All of the product won high praise from customers in the different fields.

Runda

On December 1, Runda announced that the new generation of clinical mass spectrometer - ARP-6465md triple quadrupole mass spectrometer system has been approved the national medical device registration certificate and officially listed by its subsidiary. It also indicates that Runda Medical has added heavyweight independent brand products in the field of precision medical testing, further improved the company's core competitiveness in self-produced products.

The subsidiary of Runda has focused on the field of in vitro diagnostic (IVD) precision medical detection for many years. The launch of ARP-6465md triple quadrupole mass spectrometer system has further promoted the development of high-efficiency, high-throughput and high-precision mass spectrometry detection platform, and also marked a major breakthrough in the field of clinical mass spectrometry. At the same time, it will better contribute to disease prevention, screening, diagnosis and treatment in the era of precision medicine.

ARP-6465md triple quadrupole mass spectrometer system has made unprecedented innovation for clinical testing. It has excellent performance, small model, simple operation and convenient maintenance. It can detect all mainstream tandem mass spectrometry test items such as neonatal genetic metabolic disease screening, vitamins, catecholamines, hormones, bile acid spectrum, fatty acid spectrum and blood drug concentration monitoring.

On November 30, Thermo Fisher Scientific held the unveiling ceremony of the first domestic gas chromatography-mass spectrometry in Suzhou factory. Mr. Zhou Xiaobin, vice president of business operation of analytical instrument business in China, said: congratulations on the first gas chromatography-mass spectrometry instrument produced in Suzhou, China. Thermo Fisher practices the promise of “in China, for China”, so that we can supply better and high-qualified products to Chinese users.

The localization of gas chromatography-mass spectrometry has important milestone significance, which means that Thermo Fisher has established a closer relationship with customers in China to making the world healthier, cleaner and safer.

The company actively embraces the wave of localization. The domestic instrument family of Thermo Fisher GC-MS business has expanded to 8 products: China-made liquid chromatograph, gas chromatograph, single quadrupole GC-MS, triple quadrupole GC-MS ion chromatographs, atomic absorption spectrometers, inductively coupled plasma spectrometers and inductively coupled plasma mass spectrometers have fully blossomed in vertical markets such as food, environment, industry, pharmaceutical and biopharmaceutical. All of the product won high praise from customers in the different fields.

Runda

On December 1, Runda announced that the new generation of clinical mass spectrometer - ARP-6465md triple quadrupole mass spectrometer system has been approved the national medical device registration certificate and officially listed by its subsidiary. It also indicates that Runda Medical has added heavyweight independent brand products in the field of precision medical testing, further improved the company's core competitiveness in self-produced products.

The subsidiary of Runda has focused on the field of in vitro diagnostic (IVD) precision medical detection for many years. The launch of ARP-6465md triple quadrupole mass spectrometer system has further promoted the development of high-efficiency, high-throughput and high-precision mass spectrometry detection platform, and also marked a major breakthrough in the field of clinical mass spectrometry. At the same time, it will better contribute to disease prevention, screening, diagnosis and treatment in the era of precision medicine.

ARP-6465md triple quadrupole mass spectrometer system has made unprecedented innovation for clinical testing. It has excellent performance, small model, simple operation and convenient maintenance. It can detect all mainstream tandem mass spectrometry test items such as neonatal genetic metabolic disease screening, vitamins, catecholamines, hormones, bile acid spectrum, fatty acid spectrum and blood drug concentration monitoring.